Navigation Links
PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL
Date:5/30/2008

Panel Votes, 16-0, in Favor of Short-Term Treatment of Chronic Idiopathic Thrombocytopenic Purpura (ITP)

CHICAGO, May 30 /PRNewswire-USNewswire/ -- GlaxoSmithKline (NYSE: GSK) today announced that the United States Food and Drug Administration's Oncology Drugs Advisory Committee (ODAC) unanimously voted, 16-0, that PROMACTA(R) (eltrombopag) demonstrated a favorable risk-benefit profile for the short-term treatment of patients with chronic idiopathic thrombocytopenic purpura (ITP). The FDA advisory committee was held onsite at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting.

The advisory committee reviewed studies evaluating the safety and efficacy of eltrombopag in the short-term setting. Clinical data were presented and discussed that support eltrombopag increased platelet counts and reduced bleeding.

"Chronic ITP is a condition, which can have serious complications and be life threatening. Two of the most fundamental endpoints are crucial to managing this disease -- improved platelet counts and decreased bleeding. If approved, this would make the drug a potential new clinical option that can address a true unmet medical need," said Paolo Paoletti, M.D., Senior Vice President of the Oncology Medicine Development Center at GSK. "An FDA approval for eltrombopag would represent an important development for these patients and would make the medication the first oral treatment of its kind for this disease. We look forward to working with the agency to achieve that goal."

In addition to today's recommendation, the FDA recently granted eltrombopag orphan drug designation for this indication. Orphan designation is a special status the FDA grants to products that treat a rare disease or conditio
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder
2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
3. DaVita Receives Civil Complaint
4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
9. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
10. Prime Therapeutics Receives TIPPS Certification
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2015)... CA (PRWEB) May 24, 2015 ... clear indicator that the single best option for avoiding ... reveals that fitness level was the single most powerful ... for variables such as diabetes and family history of ... of maintaining lifelong heart and lung fitness. , The ...
(Date:5/23/2015)... San Diego, CA (PRWEB) May 23, 2015 ... businesses, especially small businesses, are finding it increasingly difficult ... Those businesses which fail to provide adequate insurance for ... healthcare for businesses been such an integral part of ... provide more affordable healthcare for businesses, Online USA Doctors ...
(Date:5/23/2015)... A live auction will be held to sell ... and other medical facilities around the United States. Various ... surgery, anesthesia, exam and much more. , The live ... 28 starting at 9:00am CDT each day. The equipment is ... Melrose Park, IL 60160. Anyone can participate in the ...
(Date:5/22/2015)... May 22, 2015 The world ... and capacity are intersecting to create new opportunities ... the opening speaker at WesternU's 34th annual Commencement ... Gov. Gavin Newsom, a former San Francisco mayor ... speaker at the graduation ceremony for WesternU's colleges ...
(Date:5/22/2015)... 2015 River Valley Health Partners (RVHP) ... health system’s Chief Financial Officer (CFO), will be leaving ... as the company CFO since 2011. , The Board ... the health system as CFO. Wesley will oversee the ... the Board of Trustees conducts a formal search for ...
Breaking Medicine News(10 mins):Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2
... With the National Network to End Domestic Violence, Is ... /PRNewswire/ -- Verizon employees at ... worth of items to donate to five local domestic ... drive.Nationally, 485 Verizon locations participated in the recent companywide ...
... and playing in the backyard NORTHBROOK, Ill., May 18 ... trying to beat the heat - and recession - by ... or pool and restricting dining out to outdoor grilling. But ... also increase the potential for unnecessary accidents. With nearly half ...
... 18 AtlantaNAP ( www.atlantanap.com ), ... Health Information Designs.As a strategic initiative to consolidate their ... need for a true Tier III facility, Health Information ... center facility for its core operations. The facility ...
... AstraZeneca (NYSE: AZN ) ... for TOPROL-XL(R) (metoprolol succinate) extended release tablets have been ... near usual levels at all points in the distribution ... working to help ensure adequate market supply of TOPROL-XL ...
... GE,s Sole-Source Agreement Spans MEI,s Broad Solution Offerings ... Corporation (MEI), a subsidiary of The MEI Healthcare ... Healthcare (NYSE: GE ), a leading ... agreement offers GE Healthcare,s customers the option of ...
... Quality of Patient Care in Venipuncture, Most Common ... AccuVein LLC today ... first hand-held, non-contact vein illumination device that helps ... blood draws (venipuncture) can be a source of ...
Cached Medicine News:Health News:Verizon Employees at Five Locations in West Virginia Donate Nearly $7,000 Worth of Household Items to Local Domestic Violence Shelters 2Health News:Underwriters Laboratories Reminds Parents to Pay Attention to 'Staycation' Safety Hazards 2Health News:Underwriters Laboratories Reminds Parents to Pay Attention to 'Staycation' Safety Hazards 3Health News:GNAX/AtlantaNAP Announces Newest Client, Health Information Designs 2Health News:AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available 2Health News:AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available 3Health News:AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available 4Health News:MEI Development Corporation and GE Healthcare Sign Strategic Agreement 2Health News:Video: AccuVein Launches First Portable, Non-Contact Vein Illumination Device 2Health News:Video: AccuVein Launches First Portable, Non-Contact Vein Illumination Device 3
(Date:5/22/2015)... , May 20, 2015 Research and ... the "Guide to Prepare Application Dossiers for ... (2014 Edition) " report to their offering. ... one of segment market of the most growth ... medical device manufacturers and producers to penetrate such ...
(Date:5/22/2015)... May 22, 2015 Richmond ... research unit with a worldwide reputation for excellence ... frequent publications in peer reviewed medical journals. Its ... and regulators in discussions about rules for transparency ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical research ...
(Date:5/21/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/jx648d/north_american ... "North American Active Wound Care Market by Method ... Ulcer), by End-User (In-Patient, & Out-Paient) - Analysis ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The North American ... at a CAGR of 3.1% from 2014 to ...
Breaking Medicine Technology:China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2
... PHILADELPHIA, July 28 Shire plc (LSE: SHP,NASDAQ: ... it has received a Complete Response letter today for INTUNIV(TM),(guanfacine) ... comes following labeling discussions with the FDA that did not,result ... The FDA did not identify safety ...
... , ... , Oldsmar, Fla., July 27 Cryo-Cell ... and most established leaders in stem cell innovation today announced ... a Brazilian-based global regenerative technology leader and stem cell research ...
Cached Medicine Technology:FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents 2FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents 3FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents 4FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents 5FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents 6Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd. 2Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd. 3Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd. 4Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd. 5
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
Medicine Products: